Sangamo Therapeutics Overview

Life ScienceCompany

Where is Sangamo Therapeutics headquartered?

Sangamo Therapeutics is headquartered in Richmond, California.

What is Sangamo Therapeutics’ revenue?

Sangamo Therapeutics disclosed revenue of 58M USD for 2024 and 176M USD for 2023.

How many employees does Sangamo Therapeutics have?

Sangamo Therapeutics has 183 employees.

What sector is Sangamo Therapeutics in?

Sangamo Therapeutics is a life science company.

When was Sangamo Therapeutics founded?

Sangamo Therapeutics was founded in 1995.

Sangamo Therapeutics

Sangamo Therapeutics, Inc.

501 Canal Boulevard,
Richmond, California 94804
United States,
(510) 970-6000
www.sangamo.com

Sangamo Therapeutics is a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP nucleases (ZFNs) proteins, which could be used to modify DNA sequences in various ways; and ZFP transcription factors (ZFP TFs) proteins that could be used to turn genes on or off. The company’s principal ZFP therapeutic is SB-728-T, a ZFN-modified autologous T-cell product, which is in Phase II and Phase I/II clinical trials for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome. Sangamo Therapeutics was founded in 1995 and is based in Richmond, California.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 4 - - - - - 4
vol $121M $121M
Sell (0.0/yr) # - - - - - - 0
  4

Top M&A Advisors

Financial Deals
Alantra
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.